Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AURO-METHOTREXATE DIN 02524023

Status: Marketed
Holder: AURO PHARMA INC
Molecule: METHOTREXATE (METHOTREXATE DISODIUM)
Available to quote

Health Canada record

Active ingredient(s)METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL04AX03 METHOTREXATE
Original market date02-Feb-2023
Current status date02-Feb-2023
SourceHealth Canada DPD

Establishment licence of the holder

Auro Pharma Inc — licence 101305, currently licensed, last inspection rating C (2023-09-27).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing METHOTREXATE (METHOTREXATE DISODIUM)

DINProductCompanyFormStrengthStatus
02509067ACH-METHOTREXATEACCORD HEALTHCARE INCTabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGMarketed
02182963APO-METHOTREXATEAPOTEX INCTabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGMarketed
02546515EUGIA-METHOTREXATEEUGIA PHARMA INC.TabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGApproved
02562979JAMP METHOTREXATEJAMP PHARMA CORPORATIONTabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGApproved
02534916M-METHOTREXATEMANTRA PHARMA INCTabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGMarketed
02562839METHOTREXATE TABLETS, USPPFIZER CANADA ULCTabletMETHOTREXATE (METHOTREXATE DISODIUM) 10 MGApproved
02170698PMS-METHOTREXATEPHARMASCIENCE INCTabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
273402022-01-05Abbreviated New Drug Submission (ANDS)
Request a quote for AURO-METHOTREXATE

How to read a Canadian DIN record